219 Skin capillary density as a novel biomarker of cytotoxic and bevacizumab treatment in ovarian cancer: a prospective clinical trial

G Cass; R Lewes; J Pawade; C Newton

doi:10.1136/ijgc-2021-ESGO.359

Article info

Ovarian cancer

219 Skin capillary density as a novel biomarker of cytotoxic and bevacizumab treatment in ovarian cancer: a prospective clinical trial

Free

Authors

G Cass University Hospitals Bristol NHS Foundation Trust Headquarters, UK PubMed articles Google scholar articles
R Lewes University of Bristol, UK PubMed articles Google scholar articles
J Pawade North Bristol NHS Trust, UK PubMed articles Google scholar articles
C Newton University Hospitals Bristol NHS Foundation Trust Headquarters, UK PubMed articles Google scholar articles

Citation

Cass G, Lewes R, Pawade J, et al

219 Skin capillary density as a novel biomarker of cytotoxic and bevacizumab treatment in ovarian cancer: a prospective clinical trial

International Journal of Gynecologic Cancer 2021;31:A209-A210.

Publication history

First published October 12, 2021.

Online issue publication

January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password